Aspire Private Capital LLC Invests $1.53 Million in STERIS plc $STE

Aspire Private Capital LLC bought a new position in shares of STERIS plc (NYSE:STE) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 6,035 shares of the medical equipment provider’s stock, valued at approximately $1,530,000.

A number of other hedge funds and other institutional investors have also modified their holdings of STE. Jones Financial Companies Lllp raised its holdings in STERIS by 46.1% during the first quarter. Jones Financial Companies Lllp now owns 1,106 shares of the medical equipment provider’s stock worth $251,000 after purchasing an additional 349 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in shares of STERIS by 32.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 242,732 shares of the medical equipment provider’s stock valued at $55,015,000 after buying an additional 59,264 shares in the last quarter. Empowered Funds LLC boosted its holdings in shares of STERIS by 16.1% in the 1st quarter. Empowered Funds LLC now owns 2,303 shares of the medical equipment provider’s stock valued at $522,000 after buying an additional 319 shares in the last quarter. Woodline Partners LP grew its position in shares of STERIS by 40.0% in the 1st quarter. Woodline Partners LP now owns 8,300 shares of the medical equipment provider’s stock valued at $1,881,000 after buying an additional 2,372 shares during the last quarter. Finally, Jane Street Group LLC raised its stake in STERIS by 38.9% during the 1st quarter. Jane Street Group LLC now owns 20,716 shares of the medical equipment provider’s stock worth $4,695,000 after acquiring an additional 5,803 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on STE. Weiss Ratings reissued a “buy (b)” rating on shares of STERIS in a research report on Friday, January 9th. Wall Street Zen cut STERIS from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 28th. Six investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $275.20.

Insider Activity at STERIS

In other news, Director Cynthia L. Feldmann sold 3,098 shares of the firm’s stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $237.21, for a total value of $734,876.58. Following the completion of the sale, the director owned 705 shares in the company, valued at approximately $167,233.05. This trade represents a 81.46% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.07% of the company’s stock.

STERIS Stock Down 0.5%

STE opened at $220.01 on Thursday. STERIS plc has a 52 week low of $204.90 and a 52 week high of $269.44. The business has a 50 day moving average price of $240.19 and a two-hundred day moving average price of $248.16. The company has a quick ratio of 1.75, a current ratio of 2.48 and a debt-to-equity ratio of 0.26. The company has a market cap of $21.58 billion, a PE ratio of 30.68 and a beta of 1.07.

STERIS (NYSE:STE) last announced its earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share for the quarter, meeting the consensus estimate of $2.53. STERIS had a return on equity of 14.34% and a net margin of 12.15%.The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the prior year, the company posted $2.32 EPS. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. As a group, research analysts anticipate that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Tuesday, February 17th were given a dividend of $0.63 per share. The ex-dividend date was Tuesday, February 17th. This represents a $2.52 dividend on an annualized basis and a yield of 1.1%. STERIS’s dividend payout ratio is presently 35.15%.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.